Výsledky vyhledávání - "Rosa, Antonijoan"

Akademický článek

Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units

Autor: Paloma Moraga, Paula Prieto, Almari Conradie, Majda Benhayoun, Vicki Rousell, Maria Davy, Uwe Fuhr, Rosa Antonijoan Arbos, Francisco Abad‐Santos, Antonio Portolés, Jolanda Van Duinen, Antonio J. Carcas, Alberto M. Borobia, the ERA4TB Consortium

Publikováno v: Clinical and Translational Science, Vol 16, Iss 12, Pp 2421-2428 (2023)

Abstract First‐time‐in‐human (FTIH) trials are designed to generate information on the safety, tolerability, as well as the pharmacokinetic and pharmacodynamics profile of new drugs. To ensure the safety of participants, these trials need to be

Externí odkaz: https://doaj.org/article/d614109e5d3743f585d46e379263ac7b

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lack of Clinical Relevance of Bilastine-Food Interaction in Healthy Volunteers: A Wheal and Flare Study

Autor: Jimena Coimbra, Montserrat Puntes, Ignasi Gich, Joan Martínez, Pol Molina, Rosa Antonijoan, Cristina Campo, Luis Labeaga

Publikováno v: INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Introduction: The aim of this study was to compare the pharmacodynamic activity of bilastine administered under fasting and fed conditions in healthy volunteers. Methods: In this randomized, open-label, two-period, crossover study involving 24 health

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f9612b436aef31fb66271eb0f1f40e
https://doi.org/10.1159/000524856

Zobrazit plný text záznamu

Comparative study on the bioequivalence of two formulations of pravastatin. Data from a crossover, randomised, open-label bioequivalence study in healthy volunteers

Autor: Susana, Almeida, Augusto, Filipe, Ana, Almeida, Ignasi, Gich, Rosa, Antonijoan, Montserrat, Puntes, Manuel, Barbanoj, Maria, Cruz Caturla

Publikováno v: Arzneimittel-Forschung. 56(2)

An open-label, randomised, crossover single-dose study, using two periods, two sequences, with a minimum washout period of 7 days, was conducted in order to assess the comparative bioavailability of a pravastatin (CAS 81131-70-6) 40 mg formulation an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8b8d15842919df330dc234390ab80f50
https://pubmed.ncbi.nlm.nih.gov/16572920

Zobrazit plný text záznamu

Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers

Autor: Susana, Almeida, Augusto, Filipe, Ana, Almeida, Rosa, Antonijoan, Consuelo, García-Gea, Ignasi, Gich, Manuel, Barbanoj, Maria, Cruz Caturla

Publikováno v: Arzneimittel-Forschung. 56(2)

The bioequivalence of two capsule formulations containing 400 mg gabapentin (CAS 60142-96-3) was assessed in 24 healthy volunteers in an open, randomised, crossover, 2 periods x 2 sequences, with a minimum washout period of 7 days, single-dose study.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0802f1de13e79432479c4c8e40de7bb9
https://pubmed.ncbi.nlm.nih.gov/16572918

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání